Skip Navigation

AIDSInfo-at-a-glance

Issue No. 6 | February 06, 2009
A Service of the U.S. Department of Health and Human ServicesView HTML version
News and Features 

Updated Adult Guidelines Panel Roster and Financial Disclosure Released

The roster of the Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents has been updated to reflect the recent change in membership. The financial disclosure form has also been updated as of February 2009.

Hard Copies of the Spanish Glossary of HIV/AIDS-Related Terms Now Available!

 

On December 1, 2008, AIDSinfo released the updated sixth edition of the popular Glossary of HIV/AIDS-Related Terms in both English and Spanish. 

Now, print versions of the Spanish glossary are available for ordering from the Order Publications section of the AIDSinfo Web site!

National Black HIV/AIDS Awareness Day 2009

Tomorrow, February 7, 2009, marks the ninth annual National Black HIV/AIDS Awareness Day (NBHAAD). NBHAAD is a day dedicated to increasing awareness of HIV/AIDS in the African-American community. The goals of NBHAAD are to educate African Americans about HIV/AIDS and how it is transmitted, to encourage them to get tested, to motivate HIV-infected African Americans to seek proper treatment, and to inspire people to get involved in their community. 

Check out the updated Department of Health and Human Services' National Black HIV/AIDS Awareness Day Web page, which includes helpful links to sites providing information on health disparities, HIV/AIDS statistics, and much more--all specific to African Americans.

AIDSinfo encourages you to participate in NBHAAD by sharing this information with others.

Raltegravir Given Traditional FDA Approval

On January 29, 2009, the Food and Drug Administration (FDA) granted traditional approval for Isentress (raltegravir) 400 mg tablets in combination with other antiretroviral agents for the treatment of HIV-1 infection in treatment-experienced adult patients. The product label and patient package insert have been updated to include 48 week data from Studies 018 and 019.

Study: READY Intervention Strategy for Regimen Adherence

"This paper outlines the development and initial testing of the READY intervention that was designed to enhance readiness for adherence among adults with a history of nonadherence to HIV treatment. ... Results indicated that 50% of participants became adherent and had suppressed viral loads to less than 50 copies per milliliter at the 3-month postintervention follow-up time point. Of those who became adherent, 79% remained adherent at the 12-month postintervention follow-up time point."

  • Read the study abstract

Home | Guidelines | Clinical Trials | Drugs | Health Topics | Education Materials | Mobile Resources & Tools
Unsubscribe | Contact Us
Left footer corner image Left footer corner image